Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (331-340 of 574) with videos related to

Pageof 58
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2011
Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controlsRobert Fekete, Jose Fidel Baizabal-Carvallo, Ainhi D Ha, et al.
Neuroscience Letters|March 15, 2006
Genetic analysis of the GABRA1 gene in patients with essential tremorHao Deng, Wen-Jie Xie, Wei-Dong Le, et al.
Parkinsonism & Related Disorders|June 10, 2009
Motor overflow and mirror dystoniaOraporn Sitburana, Laura Jui Chen Wu, James K Sheffield, et al.
Journal of Molecular Recognition : JMR|September 19, 2006
A peptide-based immunoassay for antibodies against botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Philip Deitiker, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 21, 2014
Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safetyDaniel J DiLorenzo, Joseph Jankovic, Richard K Simpson, et al.
Clinical Parkinsonism & Related Disorders|February 24, 2026
Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessmentAbhishek Lenka, Ruosha Li, Karim Makhoul, et al.
Clinical Neuropharmacology|December 17, 2004
Evidence-based review of patient-reported outcomes with botulinum toxin type AJoseph Jankovic, Alberto Esquenazi, Darcy Fehlings, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-upDaniel J DiLorenzo, Joseph Jankovic, Richard K Simpson, et al.
Immunobiology|February 2, 2011
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodiesM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
Experimental Neurology|August 6, 2010
Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patientsJongil Lim, Manjit K Sanghera, Olivier Darbin, et al.
Pageof 58

Showing results (331-340 of 574) with videos related to

Sort By:
Pageof 58
Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2011
Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controlsRobert Fekete, Jose Fidel Baizabal-Carvallo, Ainhi D Ha, et al.
Neuroscience Letters|March 15, 2006
Genetic analysis of the GABRA1 gene in patients with essential tremorHao Deng, Wen-Jie Xie, Wei-Dong Le, et al.
Parkinsonism & Related Disorders|June 10, 2009
Motor overflow and mirror dystoniaOraporn Sitburana, Laura Jui Chen Wu, James K Sheffield, et al.
Journal of Molecular Recognition : JMR|September 19, 2006
A peptide-based immunoassay for antibodies against botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Philip Deitiker, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 21, 2014
Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safetyDaniel J DiLorenzo, Joseph Jankovic, Richard K Simpson, et al.
Clinical Parkinsonism & Related Disorders|February 24, 2026
Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessmentAbhishek Lenka, Ruosha Li, Karim Makhoul, et al.
Clinical Neuropharmacology|December 17, 2004
Evidence-based review of patient-reported outcomes with botulinum toxin type AJoseph Jankovic, Alberto Esquenazi, Darcy Fehlings, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-upDaniel J DiLorenzo, Joseph Jankovic, Richard K Simpson, et al.
Immunobiology|February 2, 2011
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodiesM Zouhair Atassi, Behzod Z Dolimbek, Joseph Jankovic, et al.
Experimental Neurology|August 6, 2010
Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patientsJongil Lim, Manjit K Sanghera, Olivier Darbin, et al.
Pageof 58